Belgium – Pharmaceutical products – Médicaments utilisés dans le cadre de la PMA : gonadotrophines, agoniste et antagoni
CHIREC awarded a contract of undisclosed value to Merck NV/SA for Healthcare & Medical in April 2024 — one of 47 awards this buyer has made.
Buying agency
CHIRECWinning supplier
Merck NV/SAContract description
Belgium – Pharmaceutical products – Médicaments utilisés dans le cadre de la PMA : gonadotrophines, agoniste et antagoniste de la gonadoréline
Related awards · CHIREC
47 awardsThe buyer's full award list ranked by value, with the winning supplier, date and sector on every row — plus CSV / API export.
- ocds-ted-122768-2026-1ZIMMER BIOMET€8.2M20 Feb 2026 Professional Services
- ocds-ted-122768-2026-2X.Nov IP€5.8M20 Feb 2026 Professional Services
- ocds-ted-35295-2025Teva Pharma Belgium€571K17 Jan 2025 Healthcare
Other wins · Merck NV/SA
5 winsThe supplier's complete win history across every buyer it sells to — not just the handful shown here.
- ocds-ted-226886-2024-2AZ Delta vzw€203K17 Apr 2024 Healthcare
- ocds-ted-221982-2024-4CHIRECNot disclosed15 Apr 2024 Healthcare
- ocds-ted-7821-2025-6Algemeen Ziekenhuis Jan Palfijn Gent AVNot disclosed08 Jan 2025 Healthcare
Premium · full dataset
See the full award context.
Competing bids, award margins and every related contract for CHIREC and Merck NV/SA — one subscription unlocks everything.
Sign Up Free →Free account · cancel anytime · 14-day money-back